• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

倾倒综合征中血管活性肠肽的释放

Release of vasoactive intestinal peptide in the dumping syndrome.

作者信息

Sagor G R, Bryant M G, Ghatei M A, Kirk R M, Bloom S R

出版信息

Br Med J (Clin Res Ed). 1981 Feb 14;282(6263):507-10. doi: 10.1136/bmj.282.6263.507.

DOI:10.1136/bmj.282.6263.507
PMID:6780101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1504318/
Abstract

To determine the effect of gastric surgery on the plasma vasoactive intestinal peptide (VIP) concentration, 13 patients with gastrectomy and seven controls were given an oral hypertonic load (200 ml 50% glucose solution). Blood was taken at intervals during the test for measurement of VIP and blood glucose concentrations and packed cell volume. At the same time observations were made on the occurrence of dumping symptoms and a record kept of the pulse rate. VIP values in the patients with gastrectomy were significantly increased by glucose ingestion, while these did not alter in controls (p less than 0.001). There was a highly significant correlation between the rate of rise in plasma VIP concentration and the rates of rise in packed cell volume (r = 0.85; p less than 0.001) and blood glucose concentration (r = 0.76; p less than 0.01) in patients with gastrectomy. Changes in packed cell volume and blood glucose values and the occurrence of dumping symptoms during the test were significantly different when postoperative patients were compared with controls (p less than 0.001, p less than 0.005, and p less than 0.001 respectively). Furthermore, when the patients with gastrectomy were divided into those without symptoms and those with dumping after meals the latter group showed a significantly greater rise of VIP (p less than 0.05). Despite the increased plasma VIP concentrations observed during dumping, VIP cannot be taken as the sole factor in the pathogenesis of the dumping syndrome.

摘要

为了确定胃部手术对血浆血管活性肠肽(VIP)浓度的影响,对13例胃切除患者和7例对照者给予口服高渗负荷(200 ml 50%葡萄糖溶液)。在测试期间每隔一段时间采集血液,以测量VIP、血糖浓度和血细胞比容。同时观察倾倒症状的发生情况,并记录脉搏率。胃切除患者摄入葡萄糖后VIP值显著升高,而对照组则无变化(p<0.001)。胃切除患者血浆VIP浓度的上升速率与血细胞比容的上升速率(r = 0.85;p<0.001)和血糖浓度的上升速率(r = 0.76;p<0.01)之间存在高度显著的相关性。与对照组相比,术后患者在测试期间血细胞比容和血糖值的变化以及倾倒症状的发生情况有显著差异(分别为p<0.001、p<0.005和p<0.001)。此外,将胃切除患者分为无症状组和餐后有倾倒症状组,后一组的VIP升高更为显著(p<0.05)。尽管在倾倒期间观察到血浆VIP浓度升高,但VIP不能被视为倾倒综合征发病机制中的唯一因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c24/1504318/067e697e8ebd/bmjcred00645-0012-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c24/1504318/067e697e8ebd/bmjcred00645-0012-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c24/1504318/067e697e8ebd/bmjcred00645-0012-a.jpg

相似文献

1
Release of vasoactive intestinal peptide in the dumping syndrome.倾倒综合征中血管活性肠肽的释放
Br Med J (Clin Res Ed). 1981 Feb 14;282(6263):507-10. doi: 10.1136/bmj.282.6263.507.
2
[The release of vasoactive intestinal peptide in patients with dumping syndrome and its clinical significance].[倾倒综合征患者血管活性肠肽的释放及其临床意义]
Zhonghua Wai Ke Za Zhi. 1992 Oct;30(10):616-8, 636.
3
The effect of reconstruction after subtotal gastrectomy on release of vasoactive intestinal peptide.胃大部切除术后重建对血管活性肠肽释放的影响。
Chin Med J (Engl). 1993 Aug;106(8):619-22.
4
Somatostatin and the dumping syndrome.生长抑素与倾倒综合征。
Br Med J (Clin Res Ed). 1985 Mar 23;290(6472):886-8. doi: 10.1136/bmj.290.6472.886.
5
Neurotensin, vasoactive intestinal peptide, and Roux-en-Y gastrojejunostomy. Their role in the dumping syndrome.神经降压素、血管活性肠肽与 Roux-en-Y 胃空肠吻合术。它们在倾倒综合征中的作用。
Arch Surg. 1985 May;120(5):605-9. doi: 10.1001/archsurg.1985.01390290083014.
6
Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis.倾倒综合征患者的肠道激素谱与胃排空。关于发病机制的一种假说。
Scand J Gastroenterol. 1983 Jan;18(1):73-80. doi: 10.3109/00365528309181562.
7
Long acting somatostatin analogue in dumping syndrome.长效生长抑素类似物治疗倾倒综合征
Br J Surg. 1989 Dec;76(12):1294-5. doi: 10.1002/bjs.1800761223.
8
Effect of neurotensin in the dumping syndrome.神经降压素在倾倒综合征中的作用。
Scand J Gastroenterol. 1986 May;21(4):478-82. doi: 10.3109/00365528609015165.
9
Vasoactive substances in early dumping syndrome: effects of dumping provocation with and without octreotide.早期倾倒综合征中的血管活性物质:有无奥曲肽时倾倒激发试验的影响
Eur J Clin Invest. 1997 Aug;27(8):680-4. doi: 10.1046/j.1365-2362.1997.156070.x.
10
Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy.生长抑素类似物SMS 201-995(奥曲肽)作为胃切除或迷走神经切断术后倾倒综合征的一种可能解决方案。
Br J Surg. 1989 Feb;76(2):140-4. doi: 10.1002/bjs.1800760212.

引用本文的文献

1
Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment.倾倒综合征:当前病理生理学、诊断及治疗概念综述
Dig Dis Sci. 2016 Jan;61(1):11-8. doi: 10.1007/s10620-015-3839-x. Epub 2015 Sep 22.
2
A possible role of GLP-1 in the pathophysiology of early dumping syndrome.胰高血糖素样肽-1在早期倾倒综合征病理生理学中的可能作用。
Dig Dis Sci. 2005 Dec;50(12):2263-7. doi: 10.1007/s10620-005-3046-2.
3
Sympathoadrenal activation and the dumping syndrome after gastric surgery.胃手术后的交感肾上腺激活与倾倒综合征

本文引用的文献

1
The dumping syndrome. I. Factors responsible for the symptoms.倾倒综合征。一、症状的相关因素。
Br Med J. 1960 Jan 16;1(5167):141-7. doi: 10.1136/bmj.1.5167.141.
2
The dumping syndrome. II. Cause of the syndrome and the rationale of its treatment.倾倒综合征。II. 综合征的病因及其治疗原理。
Br Med J. 1960 Jan 16;1(5167):147-51. doi: 10.1136/bmj.1.5167.147.
3
ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.抗缓激肽和血管紧张素抗体:碳二亚胺在免疫学中的一种应用
Clin Auton Res. 2000 Oct;10(5):301-8. doi: 10.1007/BF02281113.
4
Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.长效生长抑素类似物奥曲肽在术后倾倒综合征管理中的应用:最新进展
Dig Dis Sci. 1993 Feb;38(2):359-64. doi: 10.1007/BF01307556.
5
Gastric emptying after surgery for the dumping syndrome.胃切除术后倾倒综合征的胃排空情况。
Postgrad Med J. 1984 Jul;60(705):458-60. doi: 10.1136/pgmj.60.705.458.
6
Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.用生长抑素类似物SMS 201-995治疗倾倒综合征。
Ann Surg. 1988 Feb;207(2):155-9. doi: 10.1097/00000658-198802000-00007.
7
Plasma peptide YY (PYY) in dumping syndrome.
Dig Dis Sci. 1985 Dec;30(12):1145-8. doi: 10.1007/BF01314048.
8
Somatostatin and the dumping syndrome.生长抑素与倾倒综合征。
Br Med J (Clin Res Ed). 1985 Mar 23;290(6472):886-8. doi: 10.1136/bmj.290.6472.886.
9
Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.醋酸奥曲肽治疗严重胃切除术后倾倒综合征的疗效
Ann Surg. 1990 Dec;212(6):678-87. doi: 10.1097/00000658-199012000-00005.
10
Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty.胃旁路手术和垂直捆绑胃成形术前后胃肠道激素对进食的反应。
Ann Surg. 1990 Jun;211(6):763-70; discussion 770-1. doi: 10.1097/00000658-199006000-00016.
Science. 1964 Jun 12;144(3624):1344-6. doi: 10.1126/science.144.3624.1344.
4
The role of serotonin in the "dumping syndrome".
Arch Surg. 1962 Nov;85:701-4. doi: 10.1001/archsurg.1962.01310050003001.
5
The dumping syndrome and the hydrogen ion concentration of the gastric contents.倾倒综合征与胃内容物的氢离子浓度
Gut. 1974 Mar;15(3):200-6. doi: 10.1136/gut.15.3.200.
6
Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone.促胰液素组氨酸残基的酶促碘化作用:该激素的放射免疫测定法
Biochim Biophys Acta. 1973 Sep 21;322(1):178-80. doi: 10.1016/0005-2795(73)90190-6.
7
5-hydroxyindoles and kinins in the carcinoid and dumping syndromes.
Lancet. 1966 Nov 5;2(7471):986-91. doi: 10.1016/s0140-6736(66)92924-2.
8
Vasoactive intestinal peptide and watery-diarrhoea syndrome.血管活性肠肽与水样腹泻综合征
Lancet. 1973 Jul 7;2(7819):14-6. doi: 10.1016/s0140-6736(73)91947-8.
9
Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.人体内的血管活性肠肽:药代动力学、代谢及循环效应
Gut. 1978 Nov;19(11):1049-53. doi: 10.1136/gut.19.11.1049.
10
Measurement of fasting and postprandial plasma VIP in man.人体空腹和餐后血浆血管活性肠肽的测量。
Gut. 1978 Nov;19(11):1043-8. doi: 10.1136/gut.19.11.1043.